Ashwagandha Supplier Enters Australia, New Zealand Distribution

Ixoreal Biomed (Hyderabad, India) and Lipa Pharmaceuticals (Minto, Australia) have signed an agreement to distribute Ixoreal’s KSM-66 full-spectrum ashwaganda ingredient in the Australia and New Zealand territories.

KSM-66 ashwagandha can be used in dietary supplements, functional foods, and beverages. The ingredient is backed by several “gold standard” clinical trials that demonstrate its ability to act as a safe adaptogen for the body-with potential to reduce stress and improve energy levels, among other possible benefits.

Ixoreal claims to be only ashwagandha manufacturer with full control of its supply entire supply chain. The KSM-66 ingredient is manufactured without alcohol or chemical solvents.